Table 3

Asthma medications by severity

Overall
n (%)
Mild intermittent/persistent
n (%)
Moderate persistent
n (%)
Severe persistent n (%)P value
n=1649n=375n=703n=571
Short-acting bronchodilators
 Salbutamol tablets/syrup400 (24.3)75 (20.0)198 (28.2)127 (22.2)0.005
 Salbutamol inhaler894 (54.2)186 (49.6)347 (49.4)361 (63.2)<0.001
 Salbutamol/ipratropium9 (0.5)
 Nebulised salbutamol169 (10.1)32 (8.5)59 (8.4)78 (13.7)0.005
 Nebulised salbutamol/ipratropium33 (2.0)8 (2.1)14 (2.0)11 (1.9)0.963
Corticosteroids
 Nebulised steroids26 (1.6)2 (0.5)13 (1.9)11 (1.9)0.192
 Oral steroids621 (37.7)126 (33.6)280 (39.8)215 (37.7)0.185
 Injectable steroids191 (11.6)29 (7.7)92 (13.1)70 (12.3)0.033
 Inhaled steroids230 (14.0)65 (17.3)89 (12.7)76 (13.3)0.069
Combination inhalers (corticosteroids–long-acting beta agonists)
 Combination inhalers274 (16.6)56 (14.9)113 (16.1)105 (18.4)0.394
Leukotriene modifiers
 Leukotriene modifiers128 (7.8)39 (10.4)57 (8.1)32 (5.6)0.018
Other
 Theophylline/aminophylline tablets284 (17.2)40 (10.7)120 (17.1)124 (21.7)<0.001
 Theophylline/aminophylline injections219 (13.3)30 (8.0)94 (13.4)95 (16.6)0.001
 No current asthma medication206 (12.5)73 (19.5)87 (12.6)46 (8.1)<0.001
  • Data presented as count (percentage).